MX2016009355A - Inhibidores de aril lactama cinasa. - Google Patents

Inhibidores de aril lactama cinasa.

Info

Publication number
MX2016009355A
MX2016009355A MX2016009355A MX2016009355A MX2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A
Authority
MX
Mexico
Prior art keywords
kinase inhibitors
aryl lactam
lactam kinase
aryl
compounds
Prior art date
Application number
MX2016009355A
Other languages
English (en)
Inventor
M Vrudhula Vivekananda
Pan Senliang
Rajamani Ramkumar
E Macor John
J Bronson Joanne
Diane Dzierba Carolyn
Jethanand Nara Susheel
Sivasamban Karatholuvhu Maheswaran
Kumar Maishal Tarun
L Ditta Jonathan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX2016009355A publication Critical patent/MX2016009355A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos los cuales pueden inhibir a AKK1 (adaptador asociado a cinasa 1), composiciones que comprenden tales compuestos, y métodos para inhibir a AAK1.
MX2016009355A 2014-01-29 2014-01-29 Inhibidores de aril lactama cinasa. MX2016009355A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/013539 WO2015116060A1 (en) 2014-01-29 2014-01-29 Aryl lactam kinase inhibitors

Publications (1)

Publication Number Publication Date
MX2016009355A true MX2016009355A (es) 2016-10-13

Family

ID=50073525

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009355A MX2016009355A (es) 2014-01-29 2014-01-29 Inhibidores de aril lactama cinasa.

Country Status (9)

Country Link
US (1) US20160333006A1 (es)
EP (1) EP3099300B1 (es)
JP (1) JP6276865B2 (es)
CN (1) CN106132414A (es)
CA (1) CA2937529A1 (es)
EA (1) EA028587B1 (es)
ES (1) ES2693771T3 (es)
MX (1) MX2016009355A (es)
WO (1) WO2015116060A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2958924B1 (en) 2013-02-22 2016-12-28 Bristol-Myers Squibb Company 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1)
WO2015006100A1 (en) 2013-07-08 2015-01-15 Bristol-Myers Squibb Company Aryl amide kinase inhibitors
CN105979950A (zh) 2013-10-11 2016-09-28 百时美施贵宝公司 吡咯并三嗪激酶抑制剂
CA2944466C (en) 2014-04-02 2020-06-09 Bristol-Myers Squibb Company Biaryl kinase inhibitors
EP3292124B1 (en) 2015-04-10 2019-05-22 Bristol-Myers Squibb Company 6h-isochromeno[3,4-c]pyridines and benzo[c][1,7]naphthyridin-6-(5h)-ones as adaptor associated kinase 1 (aak1) inhibitors
ES2767776T3 (es) 2015-10-01 2020-06-18 Bristol Myers Squibb Co Inhibidores de biaril cinasa
CN112142655A (zh) 2015-10-01 2020-12-29 百时美施贵宝公司 联芳基激酶抑制剂
CN111825702A (zh) * 2019-04-22 2020-10-27 成都科岭源医药技术有限公司 一种氮杂*并吲唑类衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS137402A0 (en) * 2002-03-26 2002-05-09 Fujisawa Pharmaceutical Co., Ltd. Novel tricyclic compounds
WO2009017705A1 (en) * 2007-07-27 2009-02-05 Galderma Laboratories L.P. Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging
US9968574B2 (en) * 2009-05-15 2018-05-15 The University Of Kentucky Research Foundation Treatment of MCI and Alzheimer's disease
AU2010353287A1 (en) * 2010-05-13 2012-11-29 The University Of Kentucky Research Foundation Treatment of MCI and Alzheimer's disease
US8703953B2 (en) * 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
US8901305B2 (en) * 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
MX2016002924A (es) * 2013-09-11 2016-06-06 Squibb Bristol Myers Co Inhibidores de cinasa a base de eter arilico.

Also Published As

Publication number Publication date
ES2693771T3 (es) 2018-12-13
US20160333006A1 (en) 2016-11-17
EP3099300B1 (en) 2018-09-05
EP3099300A1 (en) 2016-12-07
CN106132414A (zh) 2016-11-16
JP6276865B2 (ja) 2018-02-07
EA028587B1 (ru) 2017-12-29
EA201691549A1 (ru) 2017-02-28
WO2015116060A1 (en) 2015-08-06
JP2017504630A (ja) 2017-02-09
CA2937529A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
MX2016012829A (es) Inhibidores de biaril cinasa.
PH12018501151A1 (en) Tank-binding kinase inhibitor compounds
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
PH12019550235A1 (en) Kinase inhibitors and uses thereof
PH12020500072A1 (en) Heterocyclic inhibitors of atr kinase
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
PH12017502090A1 (en) Heterocyclic amides as kinase inhibitors
MX2018009773A (es) Heteroarilos inhibidores de peptidilarginina desiminasa 4 (pad4).
MX2016015862A (es) Compuestos inhibidores de la cinasa de union a tank.
MX2016009352A (es) Inhibidores de quinasa a base de quinolina.
MX2018006632A (es) Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4).
MX2015000980A (es) Inhibidores de aril lactama cinasa.
MX2016002924A (es) Inhibidores de cinasa a base de eter arilico.
EP4327809A3 (en) Tyk2 inhibitors and uses thereof
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
MX2018001890A (es) Compuestos biciclicos como inhibidores de autotaxina (atx).
MX2017003930A (es) Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank.
NZ725917A (en) Novel polymerase-i inhibitors, uses and methods for making them
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
MX2020003706A (es) Aminoimidazopiridazinas como inhibidores de cinasa.
EA201491647A1 (ru) Основанные на арилэфирах ингибиторы киназ
MX2020003439A (es) Compuestos biciclicos para usarse como inhibidores de cinasa de la proteina 1 de interaccion con receptores (rip1).